BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31804658)

  • 21. In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome.
    Wang JT; Palme CE; Wang AY; Morgan GJ; Gebski V; Veness MJ
    J Laryngol Otol; 2013 Jan; 127 Suppl 1():S2-7. PubMed ID: 23046820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgically Treated Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: Outcome Predictors and the Role of Adjuvant Radiation Therapy.
    Kampel L; Dorman A; Horowitz G; Fliss DM; Gutfeld O; Muhanna N
    Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1016-1023. PubMed ID: 33514267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
    Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
    Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes and prognosticators in regionally recurrent cutaneous squamous cell carcinoma of the head and neck.
    Wilkie MD; Chudek DA; Flynn CD; Gaskell P; Loh C; Tandon S; Roland NJ; Jones TM; Lancaster J
    Eur J Surg Oncol; 2020 Nov; 46(11):2035-2041. PubMed ID: 32800595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
    Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
    Hung YH; Liu SA; Wang CC; Wang CP; Jiang RS; Wu SH
    PLoS One; 2018; 13(10):e0205365. PubMed ID: 30335795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.
    Smile TD; Ruiz ES; Kus KJB; Murad F; Wei W; Xiong DD; Vidimos AT; Schmults CD; Koyfman SA
    JAMA Dermatol; 2022 Apr; 158(4):390-394. PubMed ID: 35195668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival.
    Oddone N; Morgan GJ; Palme CE; Perera L; Shannon J; Wong E; Gebski V; Veness MJ
    Cancer; 2009 May; 115(9):1883-91. PubMed ID: 19224549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rates of Second Tumor, Metastasis, and Death From Cutaneous Squamous Cell Carcinoma in Patients With and Without Transplant-Associated Immunosuppression.
    Gjersvik P; Falk RS; Roscher I; Rizvi SMH; Mjøen G; Gude E; Leuckfeld I; Boberg KM; Veierød MB; Robsahm TE
    JAMA Dermatol; 2023 Sep; 159(9):923-929. PubMed ID: 37466985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases.
    Varra V; Woody NM; Reddy C; Joshi NP; Geiger J; Adelstein DJ; Burkey BB; Scharpf J; Prendes B; Lamarre ED; Lorenz R; Gastman B; Manyam BV; Koyfman SA
    Anticancer Res; 2018 Oct; 38(10):5825-5830. PubMed ID: 30275206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy.
    Toppi J; Tham YS; Webb A; Henderson MA; Rischin D; Magarey MJR
    ANZ J Surg; 2020 Jul; 90(7-8):1391-1395. PubMed ID: 32627359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient.
    McLaughlin EJ; Miller L; Shin TM; Sobanko JF; Cannady SB; Miller CJ; Newman JG
    Am J Otolaryngol; 2017; 38(3):325-328. PubMed ID: 28202188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insurance Status is Associated With Recurrence in Cutaneous Head and Neck Squamous Cell Carcinoma.
    Victor MT; Zheng W; Park SJ; Jiang SIB; Guo TW
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):132-140. PubMed ID: 37622529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence.
    Arbab M; Margalit DN; Tishler RB; Rabinowits G; Pashtan IM; Borgelt BB; Powlis W; Holdsworth CH; Warren LE; Schoenfeld JD
    Head Neck; 2019 Jul; 41(7):2111-2115. PubMed ID: 30697925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck.
    Wu MP; Sethi RKV; Emerick KS
    Laryngoscope; 2020 Jan; 130(1):108-114. PubMed ID: 30843617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Allison RS; Chaplin JM; Gregor RT; Lea R; Tan ST
    J Surg Oncol; 2008 Aug; 98(2):101-5. PubMed ID: 18523982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elective Neck Dissection for Head and Neck Cutaneous Squamous Cell Carcinoma with Skull Base Invasion.
    Cannon RB; Dundar Y; Thomas A; Monroe MM; Buchmann LO; Witt BL; Sowder AM; Hunt JP
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):671-676. PubMed ID: 28366108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases.
    Ebrahimi A; Clark JR; Ahmadi N; Palme CE; Morgan GJ; Veness MJ
    Head Neck; 2013 Aug; 35(8):1138-43. PubMed ID: 23152126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.